Several TAAs have been identified and are frequently studied in cancer research. Some of the most common include:
HER2/neu (Human Epidermal growth factor Receptor 2): Commonly overexpressed in breast and gastric cancers. CEA (Carcinoembryonic Antigen): Often elevated in colorectal, pancreatic, and lung cancers. PSA (Prostate-Specific Antigen): Used as a marker for prostate cancer. AFP (Alpha-fetoprotein): Elevated in liver cancer and germ cell tumors.